{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:05:56Z","timestamp":1791302756626,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":44,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jaip.2025.05.012","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T11:54:16Z","timestamp":1747137256000},"page":"1553-1558","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["\u201dTreat-to-Target\u201d: A Call for Earlier Targeted Intervention in Asthma"],"prefix":"10.1016","volume":"13","author":[{"given":"Simon","family":"Couillard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Pavord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Hoyte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Menzies-Gow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Lommatzsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2025.05.012_bib2","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00491-2019","article-title":"Asthma progression and mortality: the role of inhaled corticosteroids","volume":"54","author":"O'Byrne","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.05.012_bib3","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S2213-2600(23)00415-0","article-title":"Pioneering a paradigm shift in asthma management: remission as a treatment goal","volume":"12","author":"Lommatzsch","year":"2024","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2025.05.012_bib4","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/S0140-6736(22)00331-2","article-title":"Disease-modifying anti-asthmatic drugs","volume":"399","author":"Lommatzsch","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2025.05.012_bib5","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0183-2021","article-title":"Holy Grail: the journey towards disease modification in asthma","volume":"31","author":"Busse","year":"2022","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jaip.2025.05.012_bib7","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s40744-023-00601-w","article-title":"Targeting DORIS remission and LLDAS in SLE: a review","volume":"10","author":"Parra S\u00e1nchez","year":"2023","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.jaip.2025.05.012_bib8","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/02770903.2019.1591443","article-title":"Treat to target approach for asthma","volume":"57","author":"Nannini","year":"2020","journal-title":"J Asthma"},{"key":"10.1016\/j.jaip.2025.05.012_bib9","article-title":"Treat-to-target in atopic dermatitis: an international consensus on a set of core decision points for systemic therapies","volume":"101","author":"De Bruin-Weller","year":"2021","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaip.2025.05.012_bib10","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/jdv.19506","article-title":"Treat-to-target in dermatology: a scoping review and International Eczema Council survey on the approach in atopic dermatitis","volume":"38","author":"Renert-Yuval","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2025.05.012_bib11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/thoraxjnl-2021-217325","article-title":"Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide","volume":"77","author":"Couillard","year":"2022","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2025.05.012_bib12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2147\/JAA.S176026","article-title":"Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study","volume":"11","author":"Price","year":"2018","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.jaip.2025.05.012_bib13","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S2213-2600(20)30389-1","article-title":"Efficacy and safety of once-daily single-inhaler triple therapy (FF\/UMEC\/VI) versus FF\/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial. Lancet Respir Med 2021:9:69-84","volume":"9","author":"Lee","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2025.05.012_bib14","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1164\/rccm.202402-0368OC","article-title":"Association of dose of inhaled corticosteroids and frequency of adverse events","volume":"211","author":"Bloom","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2025.05.012_bib15","first-page":"44","article-title":"Tackling \u2018people remodelling\u2019 in corticosteroid-dependent asthma with type-2 targeting biologics and a formal corticosteroid weaning protocol","volume":"7","author":"St-Germaine","year":"2022","journal-title":"touchREVIEWS"},{"key":"10.1016\/j.jaip.2025.05.012_bib16","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jaip.2023.01.008","article-title":"Toward a predict and prevent approach in obstructive airway diseases","volume":"11","author":"Couillard","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.05.012_bib17","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0238-2023","article-title":"Biologic agents licensed for severe asthma: a systematic review and meta-analysis of randomised controlled trials","volume":"33","author":"Kyriakopoulos","year":"2024","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jaip.2025.05.012_bib18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S2213-2600(24)00293-5","article-title":"Clinical remission attainment, definitions, and correlates among patients with severe asthma treated with biologics: a systematic review and meta-analysis","volume":"13","author":"Shackleford","year":"2025","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2025.05.012_bib19","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.3390\/diagnostics11091637","article-title":"Lung function decline in adult asthmatics-a 10-year follow-up retrospective and prospective study","volume":"11","author":"Bucchieri","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.jaip.2025.05.012_bib20","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jaci.2019.12.006","article-title":"An expert consensus framework for asthma remission as a treatment goal","volume":"145","author":"Menzies-Gow","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.05.012_bib21","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s40744-022-00519-9","article-title":"Sustained remission and outcomes with abatacept plus methotrexate following stepwise dose de-escalation in patients with early rheumatoid arthritis","volume":"10","author":"Emery","year":"2023","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.jaip.2025.05.012_bib22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2015-207524","article-title":"Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force","volume":"75","author":"Smolen","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"80","key":"10.1016\/j.jaip.2025.05.012_bib23","article-title":"Roads to remission: evolving treatment concepts in type 2 inflammatory diseases","volume":"8","author":"Lommatzsch","year":"2025","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jaip.2025.05.012_bib24","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00819-2023","article-title":"Clinical remission in severe asthma with biologic therapy: an analysis from the UK Severe Asthma Registry","volume":"62","author":"McDowell","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.05.012_bib25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S2213-2600(24)00299-6","article-title":"Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial","volume":"13","author":"Ramakrishnan","year":"2025","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2025.05.012_bib26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S2213-2600(24)00304-7","article-title":"Asthma remission: a call for a globally standardised definition","volume":"13","author":"Lommatzsch","year":"2025","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2025.05.012_bib27","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.chest.2023.04.030","article-title":"Predicting on-biologic remission in asthma: insight from the airways","volume":"163","author":"Couillard","year":"2023","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2025.05.012_bib28","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S2213-2600(22)00490-8","article-title":"A2BCD: a concise guide for asthma management","volume":"11","author":"Lommatzsch","year":"2023","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2025.05.012_bib29","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.05.012_bib30","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1016\/j.jaip.2021.02.059","article-title":"Cluster analysis of inflammatory biomarker expression in the International Severe Asthma Registry","volume":"9","author":"Denton","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.05.012_bib31","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.jaip.2022.03.019","article-title":"Characterization of asthma by age of onset: a multi-database cohort study","volume":"10","author":"Baan","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.05.012_bib32","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.chest.2023.03.001","article-title":"Clinical remission in severe asthma: how to move from theory to practice","volume":"164","author":"Menzies-Gow","year":"2023","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2025.05.012_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update","volume":"82","author":"Smolen","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"suppl 3","key":"10.1016\/j.jaip.2025.05.012_bib34","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","article-title":"British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults","volume":"68","author":"Lamb","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jaip.2025.05.012_bib35","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.cgh.2019.02.043","article-title":"Canadian Association of Gastroenterology clinical practice guideline for the management of luminal Crohn\u2019s disease","volume":"17","author":"Panaccione","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2025.05.012_bib36","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s12325-021-01946-w","article-title":"Value of remission in patients with rheumatoid arthritis: a targeted review","volume":"39","author":"Ostor","year":"2022","journal-title":"Adv Ther"},{"key":"10.1016\/j.jaip.2025.05.012_bib37","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01509-2019","article-title":"Targeting treatable traits in severe asthma: a randomised controlled trial","volume":"55","author":"McDonald","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.05.012_bib38","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1164\/rccm.202311-2192OC","article-title":"Exploring definitions and predictors of severe asthma clinical remission after biologic treatment in adults","volume":"210","author":"Perez-de-Llano","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2025.05.012_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/CCRPM.S5100","article-title":"Achieving symptom control in patients with moderate asthma","volume":"6","author":"Weir","year":"2012","journal-title":"Clin Med Insights Circ Respir Pulm Med"},{"key":"10.1016\/j.jaip.2025.05.012_bib40","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.2147\/JAA.S327659","article-title":"Severe asthma in a general population study: prevalence and clinical characteristics","volume":"14","author":"R\u00f6nnebjerg","year":"2021","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.jaip.2025.05.012_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(25)00037-2","article-title":"Inflammatory and clinical risk factors for asthma attacks (ORACLE2): a patient-level meta-analysis of control groups of 22 randomised trials","author":"Meulmeester","year":"2025","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2025.05.012_bib42","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1080\/13696998.2022.2063603","article-title":"Carbon footprint and associated costs of asthma exacerbation care among UK adults","volume":"25","author":"Kponee-Shovein","year":"2022","journal-title":"J Med Econ"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825004362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825004362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:42:55Z","timestamp":1755650575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219825004362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2213219825004362"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2025.05.012","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201dTreat-to-Target\u201d: A Call for Earlier Targeted Intervention in Asthma","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2025.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}